Trial Profile
Effect of cabergoline in patients with schizophrenia and hyperprolactinemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2015
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary)
- Indications Hyperprolactinaemia
- Focus Therapeutic Use
- 28 Jan 2015 New trial record